ACM Global Central Lab and BioClinica Discuss How Central Lab and EDC Providers Can Collaborate More Effectively in R&D Directions Webinar

Registration is Open for Free Webinar on March 25, 2010

Rochester, NY and Newton, PA, Mar. 11, 2010 – ACM Global Central Laboratory, the global central lab that continually defines the customer-service standard with its flexible approach, and BioClinica™Inc., (NASDAQ: BIOC) a global provider of clinical trial management services, are pleased to announce they are co-sponsoring the upcoming R&D Directions webinar on, “How Central Lab and Electronic Data Capture Providers Can Collaborate Effectively.” Chris Helton, director, Data Management and Clinical Systems at ACM Global and Jonathan Andrus, VP, Data and Study Operations at BioClinica will present specific opportunities to improve collaboration and integration between EDC and central lab data.

With the emergence of standards, such as CDISC and HL7, and support from technology advances, there has never been a better time to capitalize on integration efficiencies between lab and EDC databases. Helton and Andrus will discuss best practices and recommendations for developing eCRFs that are optimized for use in conjunction with central lab data import. Participants will understand how to map and specify central lab data during the initial phases of study development that will help reduce data inconsistencies and eliminate data duplication. Regardless of whether data are imported into the EDC system, or are merged later on, collaboration between partners is paramount.

This 60-minute webinar presentation will be held on March 25, 2010, at 2:00 pm EST and will be hosted by R&D Directions. Free registration is now available by clicking here. For more information about this upcoming webinar and how to participate, visit www.rddirections.com.

About ACM Global Central Laboratory
ACM Global Central Laboratory offers a flexible approach and a focus on precision to keep clinical research studies on schedule. ACM Global’s operations extend to more than 60 countries with all tests conducted and managed from central lab facilities with seamless data management providing a single database. The organization performs 13 million tests each year, featuring more than 1,500 individual tests spanning all medical disciplines, including pathology, microbiology, flow cytometry and pharmacogenomics. Combining comprehensive safety, efficacy and pathology testing from a single lab ensures clients receive consistent, analyzable test results with faster and cleaner reporting. For more information, visit www.acmgloballab.com.

About BioClinica
BioClinica, Inc. is a leading global provider of integrated, technology-enhanced clinical trial management services. BioClinica supports pharmaceutical and medical device innovation with imaging core lab, internet image transport, electronic data capture, interactive voice and web response, and clinical supply chain design and optimization solutions. BioClinica services maximize efficiency and manageability throughout all phases of the clinical trial process. With more than 20 years of experience and over 2,000 successful trials to date, BioClinica has supported the clinical development of many new medicines from early phase trials through final approval. BioClinica operates state-of-the-art, regulatory-body-compliant imaging core labs on two continents, and supports worldwide eClinical and data management services from offices in the United States, Europe and Asia. For more information, please visit www.bioclinica.com.

email us at: info@acmgloballab.com
© ACM Global Laboratories 2017.
All rights reserved

HIPAA Privacy Statement